C D Buckner|R A Clift - JoVE Visualize

Showing results (151-160 of 306) with videos related to

Pageof 31

Sort By:

Cryobiology|October 1, 1986

Controlled rate freezing of human marrow in a constant temperature cooling gradient in airA Figuera, R S Hill, F B Petersen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cellsC H Weaver, K A Schulman, B Wilson-Relyea, et al.

Cancer Research|October 15, 1989

Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignanciesC M Higuchi, J A Thompson, T Cox, et al.

Stem Cells (Dayton, Ohio)|December 1, 1995

Transplantation of allogeneic peripheral blood stem cellsW I Bensinger, F A Appelbaum, T Demirer, et al.

Bone Marrow Transplantation|June 1, 1996

Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.

Cancer|July 15, 1994

Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed diseaseT Demirer, C D Buckner, K Lilleby, et al.

Progress in Clinical and Biological Research|January 1, 1987

Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantationA Fefer, K M Sullivan, P Weiden, et al.

The New England Journal of Medicine|May 10, 1979

Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow graftsP L Weiden, N Flournoy, E D Thomas, et al.

Bone Marrow Transplantation|August 1, 1995

Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trialM C Benyunes, C Higuchi, A York, et al.

British Journal of Haematology|September 1, 1993

Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemiaK Doney, R Storb, F R Appelbaum, et al.

Pageof 31

Showing results (151-160 of 306) with videos related to

Sort By:

Pageof 31

Cryobiology|October 1, 1986

Controlled rate freezing of human marrow in a constant temperature cooling gradient in airA Figuera, R S Hill, F B Petersen, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cellsC H Weaver, K A Schulman, B Wilson-Relyea, et al.

Cancer Research|October 15, 1989

Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignanciesC M Higuchi, J A Thompson, T Cox, et al.

Stem Cells (Dayton, Ohio)|December 1, 1995

Transplantation of allogeneic peripheral blood stem cellsW I Bensinger, F A Appelbaum, T Demirer, et al.

Bone Marrow Transplantation|June 1, 1996

Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant diseaseK S Schiffman, W I Bensinger, F R Appelbaum, et al.

Cancer|July 15, 1994

Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed diseaseT Demirer, C D Buckner, K Lilleby, et al.

Progress in Clinical and Biological Research|January 1, 1987

Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantationA Fefer, K M Sullivan, P Weiden, et al.

The New England Journal of Medicine|May 10, 1979

Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow graftsP L Weiden, N Flournoy, E D Thomas, et al.

Bone Marrow Transplantation|August 1, 1995

Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trialM C Benyunes, C Higuchi, A York, et al.

British Journal of Haematology|September 1, 1993

Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemiaK Doney, R Storb, F R Appelbaum, et al.

Pageof 31